European universities dismal at reporting results of clinical trials

US universities are also pretty bad: <a href="https:&#x2F;&#x2F;blogs.sciencemag.org&#x2F;pipeline&#x2F;archives&#x2F;2018&#x2F;09&#x2F;20&#x2F;reporting-clinical-trials" rel="nofollow">https:&#x2F;&#x2F;blogs.sciencemag.org&#x2F;pipeline&#x2F;archives&#x2F;2018&#x2F;09&#x2F;20&#x2F;re...</a>, although Europe seems to be doing a worse job at complying with mandatory reporting in general.<p>Funnily enough, everyone with 100% compliance is a Big Pharma company, while everyone with 0% compliance is an academic university.

It&#x27;s starting to seem like we agressively discuss a lot of proposed European rules here on HN. But, when they come into effect they&#x27;re immediately ignored by the people who should be complying and the people who should be enforcing.

An interesting read on the effects of FDA trial registration requirements and publication bias: <a href="https:&#x2F;&#x2F;www.ncbi.nlm.nih.gov&#x2F;pmc&#x2F;articles&#x2F;PMC6199729&#x2F;" rel="nofollow">https:&#x2F;&#x2F;www.ncbi.nlm.nih.gov&#x2F;pmc&#x2F;articles&#x2F;PMC6199729&#x2F;</a>

How many of these studies are conducted in English vs. the legacy local language?